Crystalvue Medical Corporation (6527.TWO) stock: key figures, P/E, revenue and dividend

Health Care · Taiwan

Price
71.50 TWD
Market cap
1.81 bn TWD
P/E (2025)
12.33
P/S (2025)
1.91
Dividend yield
4.06 %
Net margin
15.49 %
Return on equity (ROE)
14.29 %
Return on assets (ROA)
11.35 %

Crystalvue Medical Corporation financials

Fiscal year20242025
Revenue868.03 m TWD949.05 m TWD
Gross profit299.14 m TWD331.88 m TWD
Operating income145.01 m TWD180.95 m TWD
EBIT160.01 m TWD179.47 m TWD
Net income127.15 m TWD146.98 m TWD
Diluted EPS – continuing operations5.04 TWD5.80 TWD

Full history since 2019, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Crystalvue Medical Corporation

Crystalvue Medical Corporation manufactures and sells medical devices worldwide. The company offers optical coherence tomography, retinal cameras, tonometers, lens edgers, and gastroenterology supplies, as well as ODM/OEM services for automated nucleic acid extraction instrument and PCR system. It also sells minimal invasive endoscopic instrument supplies. The company was founded in 2009 and is based in Taoyuan City, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.